A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases
NCT07448298
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Relapsed/Refractory Autoimmune Diseases
Interventions
BIOLOGICAL:
AFN50 injection
Sponsor
Beijing Boren Hospital